|
Ipilimumab combined with stereotactic radiosurgery in melanoma patients with brain metastases: A multicenter, open label, phase 2 trial. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Boehringer Ingelheim |
Travel, Accommodations, Expenses - Chugai Pharma |
|
|
Honoraria - Bristol-Myers Squibb |
Consulting or Advisory Role - Galderma; Novartis; Sanofi/Aventis |
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Novartis; Sanofi/Aventis |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Roche |
Research Funding - Roche (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Roche Pharma AG |
Research Funding - Novartis |
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Pierre Fabre |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Novartis; Roche |
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma |
Consulting or Advisory Role - Amgen; BMS Brazil; Merck; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma |
Speakers' Bureau - Novartis |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Mundipharma; Novartis |
Consulting or Advisory Role - Abbvie; Daiichi Sankyo |
Research Funding - Amgen (Inst); Mundipharma (Inst) |